Brief: Dicot Pharma Announces Outcome In Oversubscribed Rights Issue
BRIEF-Dicot Pharma Announces Outcome In Oversubscribed Rights Issue June 9 (Reuters) - Dicot Pharma AB DICOT.ST:
ABOUT 134% OF THE RIGHTS ISSUE HAS BEEN SUBSCRIBED WITH AND WITHOUT THE SUPPORT OF UNIT RIGHTS, CORRESPONDING TO 207,242,556 UNITS
AS RIGHTS ISSUE WAS OVERSUBSCRIBED, BOARD RESOLVES ON DIRECTED ISSUE OF 15,456,480 UNITS CORRESPONDING TO ABOUT SEK 21 MILLION
Further company coverage: DICOT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Dicot Pharma AB
See all newsBrief: Dicot Pharma Recruits Cecilia Driving As CFO
Brief: Dicot Pharma Gets FDA Clearance To Start First Part Of Phase 2B Study With Lib-01 In U.S.
Brief: Dicot Pharma Announces Outcome In Oversubscribed Rights Issue
Brief: Dicot Pharma Announces Prelim Rights Issue Outcome
Brief: Dicot Pharma Submits IND Application To FDA